Severe ADC decreases do not predict irreversible tissue damage in humans.
about
Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onsetBrain imaging in stroke: insight beyond diagnosis.MR imaging of oxygen extraction and neurovascular coupling.Selective neuronal loss in ischemic stroke and cerebrovascular diseaseImaging of cerebral ischemia: from acute stroke to chronic disordersProspective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus studyImaging of the ischemic penumbra in acute stroke.Imaging of cerebral perfusion in acute stroke.Acute stroke imaging for thrombolytic therapy--an update.Modern imaging of the infarct core and the ischemic penumbra in acute stroke patients: CT versus MRI.Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.Imaging stroke patients with unclear onset times.Early nonischemic oxidative metabolic dysfunction leads to chronic brain atrophy in traumatic brain injury.Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.Early diffusion-weighted imaging reversal after endovascular reperfusion is typically transient in patients imaged 3 to 6 hours after onset.Defining the ischemic penumbra using hyperacute neuroimaging: deriving quantitative ischemic thresholdsMRI-guided therapy in acute stroke.Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent.Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to dateImaging the physiological evolution of the ischemic penumbra in acute ischemic stroke.How healthy is the acutely reperfused ischemic penumbra?Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders.The Massachusetts General Hospital acute stroke imaging algorithm: an experience and evidence based approach.High b value DWI in evaluation of the hyperacute cerebral ischemia at 3T: A comparative study in an embolic canine stroke model.Automated decision-support system for prediction of treatment responders in acute ischemic stroke.Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR.Multiphasic perfusion CT in acute middle cerebral artery ischemic stroke: prediction of final infarct volume and correlation with clinical outcome.Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin LabelingRefining the mismatch concept in acute stroke: lessons learned from PET and MRIDWI Reversibility after Intra-Arterial Thrombolysis. A Case Report and Literature Review.Stroke penumbra defined by an MRI-based oxygen challenge technique: 2. Validation based on the consequences of reperfusion.Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients - a position paper endorsed by ESMINT and ESNR : part II: methodology of future trials.Magnetic resonance characterization of ischemic tissue metabolism.Comparative study of the relative signal intensity on DWI, FLAIR, and T2 images in identifying the onset time of stroke in an embolic canine model.Selective cognitive patterns resulting from bilateral hippocampal ischemia.Magnetic resonance imaging and spectroscopy: how useful is it for prediction and prognosis?Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia.Stratification of heterogeneous diffusion MRI ischemic lesion with kurtosis imaging: evaluation of mean diffusion and kurtosis MRI mismatch in an animal model of transient focal ischemia.Stroke penumbra defined by an MRI-based oxygen challenge technique: 1. Validation using [14C]2-deoxyglucose autoradiography.
P2860
Q30470195-38AC0744-21AC-4439-9418-ED43ADF6D92FQ30502893-72BABA89-EFD2-4925-9A6E-C3586EF5A5D4Q30633369-39610877-C768-42B2-B71A-7F3843079F21Q30689231-A482451E-5A97-4FC4-9A70-4784878BCA15Q30703669-DD52C479-809D-4EA2-ADFB-B6E118F932F2Q30967468-6C4EAE2C-EB8E-472D-991C-86C90804C474Q30992496-655A77E6-5CAF-4E04-A704-EA1235ECDD21Q31008287-4C57DB91-BC2C-462F-B620-7DDBA245A952Q31116988-8ED34B16-F8A3-47D9-9F75-2CDD3D3258D9Q33432257-FA894C03-9134-44CF-B653-E6727DECFC0DQ33604155-44FBF470-9DA2-45AB-9437-CB4297233E35Q33922452-53004486-5C07-40A7-B4B3-D55F4B5DE250Q34170935-A3D1BEB9-19D4-439D-BBDD-CEBDDBCA3747Q35262173-E76EC981-CDD5-4568-A786-44AF81AA5C70Q35414080-437A4E6D-A7C3-421C-9268-F5BA3EF2AA28Q35624277-E8CFC143-8592-48BC-8BDF-D0904C321EACQ35696214-93FA887D-A92F-4441-9AAC-C46FD02AFD86Q36062891-97F05740-A484-4548-B884-E2665FA78941Q36227432-750D2438-EC2A-41AE-9603-7C9687016272Q36323511-7819BEA9-D3A3-474E-863E-4B9B4895C2C1Q36331000-EC9DD527-B674-471F-8803-DD37CDB20112Q36561991-5E930DE8-7175-48B0-9F0E-1A0823913133Q36756953-09B8E72B-5685-49F9-B595-1D2500036CDDQ37107785-A286626C-A2CA-4B65-9238-743C66C2BBFCQ37199449-ADA3E798-C507-4B29-BC7B-FA47380C1F9DQ37259692-299750DD-09E5-4107-9400-E67A6AA2A899Q37270193-29E49F7D-E337-4ACB-951E-390F0FCF561CQ37524051-688AE8AD-6F48-4DD9-ABDB-8241BD08FBD4Q38003250-18CA753E-9218-4A64-B197-5A30764978D2Q38154723-823352B4-5113-4DC5-810B-7BFFA7FF70B4Q38255996-8B6FE656-CAD8-46B3-95CE-2FA49A3B4BB6Q38641106-005687C3-1495-4BA3-96E7-3DD0737914B3Q39558458-13901B19-5802-4A71-A904-F146FBD029D0Q39979430-1771B726-6FD7-4182-9CB6-69B4A3DFC262Q40168693-81FD7A4B-A780-4F1B-AE55-14E5143B3AEDQ40414066-4AF42880-F487-4206-B922-C65DBF8E93A3Q41829224-1EFDE156-B8F9-4E6F-9732-15EDF5F00B52Q41849146-0ACF52F2-FA6C-4EC7-8A49-BFD351F82415Q42262196-7BB2B121-FF3B-46D2-B706-471E139AB616Q42270352-05F12FB9-8219-43F0-818F-379EA973647B
P2860
Severe ADC decreases do not predict irreversible tissue damage in humans.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Severe ADC decreases do not predict irreversible tissue damage in humans.
@en
type
label
Severe ADC decreases do not predict irreversible tissue damage in humans.
@en
prefLabel
Severe ADC decreases do not predict irreversible tissue damage in humans.
@en
P2093
P356
P1433
P1476
Severe ADC decreases do not predict irreversible tissue damage in humans.
@en
P2093
Cornelius Weiller
Hermann Zeumer
Jens Fiehler
Joachim Röther
Mascha Foth
Michael von Bezold
Renée Knab
Thomas Kucinski
P356
10.1161/HS0102.100884
P407
P577
2002-01-01T00:00:00Z